Related Experiment Video
Updated: May 8, 2026

Imaging Initial Ca2+ Microdomains in Primary T Cells
Published on: October 4, 2024
Role of Ca2+-activated KCa3.1 potassium channel in CAR T cell effector function
Vivien Jusztus1, Márton Hajdu1, Péter Horváth1
1Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Inhibiting the KCa3.1 ion channel in chimeric antigen receptor (CAR) T cells enhances their ability to kill tumor cells. This modification of KCa3.1 channels boosts CAR T-cell effectiveness in cancer immunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Chimeric antigen receptor (CAR) T cells are engineered immune cells for cancer therapy.
- T cell ion channels, including KCa3.1, regulate T cell function and calcium signaling.
- CAR T cell efficacy is influenced by their activation, proliferation, and cytotoxic activity.
Purpose of the Study:
- To investigate the role of the KCa3.1 ion channel in CAR T cell-mediated tumor cell killing.
- To determine if inhibiting KCa3.1 enhances CAR T cell effector functions.
- To explore the impact of KCa3.1 modulation on CAR T cell migration and calcium signaling.
Main Methods:
- Utilized genetically modified Jurkat cells expressing CARs to target Raji B tumor cells.
- Administered TRAM34, a specific KCa3.1 inhibitor, to assess its effects on CAR T cells.
- Monitored tumor cell elimination, CAR T cell migration (speed, displacement, distance), and intracellular calcium levels (Ca2+).
Main Results:
- Inhibition of KCa3.1 by TRAM34 significantly increased the tumor cell-killing capacity of CAR T cells.
- KCa3.1 blockade enhanced CAR T cell migration.
- TRAM34 application reduced baseline intracellular Ca2+ levels in CAR T cells.
- The time required for tumor cell elimination was substantially decreased with TRAM34 treatment.
Conclusions:
- Modulating KCa3.1 ion channels shifts intracellular Ca2+ concentration, favoring enhanced cytotoxicity.
- Targeting KCa3.1 represents a potential strategy to improve the efficacy of CAR T-cell immunotherapy against cancer.
- KCa3.1 channel modification offers a promising avenue for developing more effective anti-cancer treatments.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential.
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...

